Skip to content

Cytek Biosciences, Inc. CTKB Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.46B-17.9%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.42B+11.3%
Danaher logo
DanaherDHR
$5.57B-1.3%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$9.37M+53.1%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$6.42M+18.9%
TEC
Bio-TechneTECH
$21.67M+38.4%

Other financials

Income statement

See full
Revenue$44.1M+6.5%
Gross profit$21.3M+5.4%
Operating income-$18.5M-23.3%
Net income-$18.9M-65.5%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$31.8M-66.6%
Total debt$16.8M+40.9%
Total equity$327.6M-13.7%
Total assets$449.1M-6.9%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+155%
Free cash flow-$4.9M-403%

Valuation

See full
Market cap$577.27M+54.5%
Enterprise value$562.23M+93.7%
P/S2.8×+0.9×

Profitability

See full
Gross margin51.7%-3.2pp
Operating margin-21.5%
Net margin-36.2%
FCF margin-6.2%-15.1pp

Returns & leverage

See full
Return on equity-20.9%
Debt / equity0.1×0.0×
Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s other non-current liabilities?
Cytek Biosciences, Inc. (CTKB) reported other non-current liabilities of $2.4M in Q1 2026.
How has Cytek Biosciences, Inc.'s other non-current liabilities changed year-over-year?
Cytek Biosciences, Inc.'s other non-current liabilities increased by 0.8% year-over-year, from $2.38M to $2.4M.
What is the long-term trend for Cytek Biosciences, Inc.'s other non-current liabilities?
Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s other non-current liabilities has grown at a 25.6% compound annual growth rate (CAGR), from $737K to $2.31M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.